IRIS PubliCatt

Borghetti, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.274
EU - Europa 2.239
AS - Asia 850
AF - Africa 52
OC - Oceania 26
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 5.458
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.228
IT - Italia 561
SE - Svezia 480
SG - Singapore 313
DE - Germania 268
PL - Polonia 219
CN - Cina 211
FR - Francia 199
IE - Irlanda 140
GB - Regno Unito 106
ID - Indonesia 91
FI - Finlandia 69
IN - India 69
UA - Ucraina 56
CA - Canada 42
RU - Federazione Russa 38
IR - Iran 27
BE - Belgio 26
AU - Australia 25
TR - Turchia 20
SA - Arabia Saudita 19
NL - Olanda 16
CI - Costa d'Avorio 15
PH - Filippine 15
HK - Hong Kong 14
AT - Austria 11
PK - Pakistan 11
MY - Malesia 10
CH - Svizzera 9
EG - Egitto 9
VN - Vietnam 8
TW - Taiwan 7
ES - Italia 6
TN - Tunisia 6
BD - Bangladesh 5
CZ - Repubblica Ceca 5
GR - Grecia 5
LT - Lituania 5
NG - Nigeria 5
BR - Brasile 4
EU - Europa 4
IL - Israele 4
MA - Marocco 4
PT - Portogallo 4
RO - Romania 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
DK - Danimarca 3
JO - Giordania 3
MD - Moldavia 3
NP - Nepal 3
SD - Sudan 3
TH - Thailandia 3
BG - Bulgaria 2
CL - Cile 2
CM - Camerun 2
JP - Giappone 2
KE - Kenya 2
LK - Sri Lanka 2
MG - Madagascar 2
MM - Myanmar 2
MO - Macao, regione amministrativa speciale della Cina 2
NO - Norvegia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CY - Cipro 1
EC - Ecuador 1
GL - Groenlandia 1
IM - Isola di Man 1
IQ - Iraq 1
KW - Kuwait 1
LU - Lussemburgo 1
MX - Messico 1
NZ - Nuova Zelanda 1
PE - Perù 1
PR - Porto Rico 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 5.458
Salva come PNG Salva come JPEG
Città #
Chandler 616
Singapore 244
Ashburn 231
Kraków 209
Milan 148
Dublin 137
New York 128
Rome 114
Jakarta 91
San Mateo 79
Jacksonville 60
Boston 58
Ann Arbor 47
Helsinki 47
Princeton 47
Wilmington 47
Marseille 40
Redmond 33
Nanjing 32
Los Angeles 29
Moscow 29
Chicago 28
Beijing 27
Lancaster 27
Cattolica 26
Brussels 23
Boardman 22
Dearborn 20
Houston 20
London 20
Pune 18
Fairfield 17
Lawrence 17
Abidjan 15
Woodbridge 15
Augusta 14
Munich 14
Toronto 14
Bremen 13
Redwood City 13
Seattle 13
Norwalk 12
Amsterdam 11
Dammam 11
Izmir 11
Kish 11
Nürnberg 11
Washington 11
Vienna 10
Andover 9
Warsaw 9
Cambridge 8
Changsha 8
Hong Kong 8
Ottawa 8
Sydney 8
Al Qatif 7
Frankfurt am Main 7
Leawood 7
Santa Clara 7
Oggiono 6
Shenyang 6
Cairo 5
Ferrara 5
Guangzhou 5
Lahore 5
Nanchang 5
Naples 5
Paris 5
St Louis 5
Swansea 5
Taipei 5
Tianjin 5
Zurich 5
Bari 4
Boydton 4
Cape Town 4
Castelfranco Emilia 4
Delhi 4
Falls Church 4
Hebei 4
Hefei 4
Jinan 4
Lappeenranta 4
Phoenix 4
Robbiate 4
Sacramento 4
Shanghai 4
Springfield 4
Thrissur 4
Amman 3
Bacolod City 3
Berlin 3
Bournemouth 3
Brno 3
Busto Arsizio 3
Castignano 3
Central 3
Clearwater 3
Dhaka 3
Totale 3.182
Salva come PNG Salva come JPEG
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 431
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk 170
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 165
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 160
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 147
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients 139
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 134
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients 133
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 124
Ophthalmic artery resistance index IS increased in HIV-Infected patients and is influenced by protease inhibitors exposure 123
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial 120
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 106
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 105
Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study 100
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients 95
Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients 92
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 91
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 86
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 82
Psychological distress during the initial stage of the COVID-19 pandemic in an italian population living with HIV: An online survey 82
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 77
Prevalence, incidence and predictors of anal high-risk HPV infections and cytological abnormalities in HIV-infected individuals 76
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 76
HIV-Related Internalized Stigma and Patient Health Engagement Model in an Italian Cohort of People Living With HIV 76
Shall we dance? Extending tango's results to clinical practice 73
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients 73
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 72
Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line 71
Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV 71
Residual respiratory impairment after COVID-19 pneumonia 71
Simplification to a dual regimen with darunavir/ritonavir plus lamivudine or emtricitabine in virologically-suppressed HIV-infected patients 66
Use of Long-Acting Therapies for HIV Care in Italy: Are People Living with HIV Prepared for Change? A Cross-Sectional Study 65
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 64
Seroprevalence of sars-cov-2 antibodies in hiv-infected patients in rome, italy during the covid-19 outbreak 60
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 60
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir–rilpivirine in clinical practice 58
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy 57
Use of telehealth for HIV care in Italy: Are doctors and patients on the same page? A cross-sectional study 57
Risk of Tumor Onset in HIV+ Patients on Two-Drug Regimens: A Cohort Study in an Italian Hospital 57
Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive 56
Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study 55
No evidence of SARS-CoV-2 circulation in HIV-infected patients between December 2019 and February 2020 in Rome, Italy 55
Short Communication: Comparing Lamivudine+Dolutegravir and Bictegravir/Emtricitabine/Tenofovir Alafenamide as Switch Strategies: Preliminary Results from Clinical Practice 54
Residual respiratory impairment after COVID-19 pneumonia 53
SARS-CoV-2 infection in a highly experienced person living with HIV 53
People Living with HIV in the COVID-19 Era: A Case Report 52
Determinants of SARS-COV-2 seroconversion in a cohort of recovered patients 52
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 52
Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection 49
Focal status epilepticus as unique clinical feature of COVID-19: A case report 48
Inflammation markers in virologically suppressed HIV-Infected patients after switching to dolutegravir plus lamivudine vs continuing triple therapy: 48-week results in real-life setting 47
Off-label use of tocilizumab in patients with SARS-CoV-2 infection 45
Virological outcomes with dolutegravir plus either lamivudine or two NRTIs as switch strategies: a multi-cohort study 45
Cardiovascular Disease Risk in a Cohort of Virologically Suppressed People Living with HIV Switching to Doravirine: Preliminary Data from the Real Life 42
Comparative safety review of recommended, first-line single-tablet regimens in patients with HIV 40
The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic 39
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV 38
Early use of tecovirimat in a young man with severe mpox skin lesions: a case report 37
People Living with HIV in the COVID-19 Era: A Case Report 37
Functional associations between polymorphic regions of the human 3'IgH locus and COVID-19 disease 36
Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors 36
Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections 36
Short Communication: Efficacy and Safety of Dolutegravir plus Lamivudine as a First-Line Regimen in Clinical Practice 35
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 34
COVID-19 diagnosis does not rule out other concomitant diseases 33
No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine-Dolutegravir 32
Comparison of HIV-DNA decay in naive patients starting dolutegravir plus lamivudine or dolutegravir-based triple therapy 32
Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients during Lamivudine plus Dolutegravir Maintenance Therapy in Clinical Practice 31
Real-life findings on the impact of the COVID-19 pandemic on HIV care 31
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy 30
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients 26
Kaposi-like manifestations in a newly diagnosed aids transgendered patient with silicone embolism syndrome and disseminated tuberculosis 21
Impact of resistance mutations on efficacy of dolutegravir plus rilpivirine or plus lamivudine as maintenance regimens: a cohort study 21
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 19
HIV and vicarious stigma in a cohort of people living with HIV in Italy: What happens when the stigma is fueled by healthcare providers? 18
Nasopharingeal bacterial and fungal colonization in HIV-positive versus HIV-negative adults 18
Treatment of Aorto-iliac and Infrainguinal Vascular Infections with a Prefabricated Bovine Pericardial Graft 17
Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic Study 16
The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic 15
Atypical ductal hyperplasia on vacuum-assisted breast biopsy: a scoring system to predict the risk of upgrade to malignancy 15
Evolution of cellular HIV DNA levels in virologically suppressed patients switching to dolutegravir/lamivudine versus maintaining a triple regimen: a prospective, longitudinal, matched, controlled study 14
The association between stigma and wellbeing in an Italian cohort of PLWH: The role of social support and personal factors 13
Differences in the Long-term Impact of the COVID-19 Pandemic on the Mental Health and Professional Quality of Life of Resident and Specialist Physicians 12
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study 12
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 12
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed 11
Characteristics of mental health interventions in a cohort of Italian PLWH over the last five years: impact of HIV disease and outbreak of COVID-19 pandemic 11
Letter to the Editor: Real-Life Experience of Long-Acting Cabotegravir-Rilpivirine Combination in a Person Living with HIV with Detectable Viremia: A Case Report 10
Changes in Metabolic Profile in PLWHIV Switching to Doravirine-Based Regimen 9
New insight of human-IgH 3′regulatory regions in immunoglobulins switch 9
Clinical presentation of human monkeypox virus infection during the 2022 outbreak: descriptive case series from a large italian Research Hospital 7
Totale 5.586
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.958
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020160 0 0 0 0 24 25 16 14 13 16 34 18
2020/2021234 4 15 4 13 16 21 21 10 39 36 44 11
2021/2022695 33 21 16 73 19 22 65 116 31 52 85 162
2022/20232.016 207 253 176 322 209 269 82 154 217 54 54 19
2023/20241.103 43 223 36 98 59 179 76 30 39 51 135 134
2024/2025579 27 54 256 85 157 0 0 0 0 0 0 0
Totale 5.586